Medicine & Life Sciences
Nicotine
100%
Tobacco Products
83%
Prostatic Neoplasms
50%
Biomarkers
39%
Smokers
35%
Smoking
27%
Randomized Controlled Trials
27%
Medical Futility
19%
Single Nucleotide Polymorphism
18%
Clinical Trials
17%
Multiparametric Magnetic Resonance Imaging
16%
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
15%
Cigarette Smoking
15%
Sample Size
15%
Tobacco
15%
Neoplasms
14%
2-amino-9H-pyrido(2,3-b)indole
13%
Dogs
13%
Text Messaging
13%
Cotinine
13%
Area Under Curve
12%
Placebos
12%
Population
12%
Phase II Clinical Trials
12%
Ovarian Neoplasms
12%
Smoke
12%
Hemangiosarcoma
10%
valspodar
10%
Lymphoid Progenitor Cells
10%
Maximum Tolerated Dose
10%
Clinical Trials, Phase I
10%
Ebola Hemorrhagic Fever
10%
Compliance
10%
Therapeutics
9%
Gastroschisis
9%
Safety
9%
Prostate
9%
Sensitivity and Specificity
9%
Asian Americans
9%
African Americans
9%
Cell Phone
8%
Hyperbilirubinemia
8%
Standard of Care
8%
Losartan
8%
Confidence Intervals
7%
O(6)-(4-oxo-4-(3-pyridyl)butyl)guanine
7%
Parenteral Nutrition
7%
Telemedicine
7%
Amines
7%
Mathematics
Biomarkers
33%
Prostate Cancer
20%
Early Termination
20%
Continual Reassessment Method
16%
Clinical Trials
16%
Noncompliance
15%
Group Sequential
14%
Design
13%
Causal Effect
13%
Exchangeability
13%
Voxel
12%
Toxicity
10%
Randomized Trial
9%
Sequential Testing
9%
Cancer Classification
9%
Compliance
8%
Hierarchical Modeling
8%
Trivariate
8%
Treatment Effects
8%
Bayesian Model
8%
Magnetic Resonance Imaging
8%
Bayesian Modeling
7%
Estimator
7%
Specificity
6%
Estimate
6%
Simulation
6%
Curve
6%
Cancer
6%
Information Sharing
5%
Classifier
5%
Operating Characteristics
5%
Sample Size
5%
Surrogate
5%
Diagnostics
5%
Case-control
5%
Standards
5%
Phase I Trial
5%
Randomized Clinical Trial
5%
Evaluate
5%
Modeling
5%
